GLOBAL LIVER INSTITUTE
Leading health organizations, policymakers, and public health advocates will come together during the 78th World Health Assembly (WHA78) for a pivotal side event titled “Together for Better Liver Health – Strengthening Public Health Responses to Metabolic Disease”.
Chronic infection of the liver by hepatitis B virus (HBV) remains a significant public health concern in the U.S. and around the world, particularly among at-risk populations.
Key House authorizing committees are slated to kick off markups on their respective budget reconciliation instructions that will be combined into a single reconciliation bill.
The introduction of new, dedicated ICD-10 diagnosis codes for Fontan-associated conditions in the U.S. Centers for Medicare & Medicaid Services (CMS) FY 2026 IPPS Proposed Rule marks a significant step forward for patients who have undergone the Fontan procedure.
Global Liver Institute brings you key updates in liver cancer research and treatment.
I recently conducted a workshop titled: Advanced Strategies: Navigating Credible Research and Accessing Clinical Trial Opportunities, as part of GLI’s A4 ,program with a focus on clinical research participation.
On Friday, April 4, 2025, the U.S. Centers for Medicare and Medicaid (CMS) released the 2026 Medicare Advantage and Part D Final Rule and decided not to finalize the proposed rule to extend obesity treatment coverage to Medicare and Medicaid beneficiaries.
Medicaid cuts are still under consideration in Congress as the House pushes for the Senate to accept its version of a budget reconciliation package.
Join us on Monday, April 21, 2025, at 3:00 PM PST | 6:00 PM EST for GLI’s Liver Cancer Lessons: Liver Disease Prevention Through Nutrition, an educational webinar that discusses the impact nutrition has on liver health.
Global Liver Institute is excited to announce the appointment of Dr. Sharon Jaycox as the new Fatty Liver Disease Program Director.
Growing up in rural Mississippi, MiKayla believed that opportunities in science were reserved for people from well-connected backgrounds.
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV) that can cause long-term (chronic) disease. Chronic hepatitis B can lead to serious liver damage – including scarring (cirrhosis), liver failure, and even liver cancer.
